Aminopeptidases

 Enzymes that catalyze the hydrolytic cleavage of the peptide bond that connects the N-terminal residue to the rest of a peptide, polypeptide, or protein are referred to as aminopeptidases (E.C. 3.4.11) (see Peptidases). The products of hydrolysis are, therefore, the released N-terminal amino acid and the remainder of the peptide chain. The latter can, in turn, also be an aminopeptidase substrate; hence these enzymes can release amino acids sequentially, ultimately resulting in complete hydrolysis of the polypeptide (though in practice this is not always observed). The principal determinant of specificity appears to be the free a-amino group of the N-terminal residue; hence these enzymes can release most, though not all, of the known amino acids, albeit at different rates. There are some aminopeptidases (eg, methionine aminopeptidase) that are quite limited in specificity. Usually, aminopeptidases can also act on amino acid amides and esters, which provide convenient substrates for routine assays. Some aminopeptidases sequentially remove dipeptides from the N-terminus of substrates, and these are referred to as dipeptidyl-peptidases. Others remove tripeptides and, hence, are tripeptidyl-peptidases.

Many aminopeptidases are zinc metalloenzymes, but some are serine proteinases or thiol proteases. Of those that require zinc, some have an active site containing a single ion, whereas others have a co-catalytic site that involves two closely spaced zinc ions.

 Aminopeptidases are widely distributed in various tissues and cells. They can be monomeric (a single polypeptide chain) or have up to 12 subunits. Many are integral components of cell membranes, but they are also found in the cytosol. They have a broad range of biological functions, including regulation of hormone concentration, control of the cell cycle, and recovery of amino acids from dietary peptides and proteins (1). All proteins synthesized by eukaryotic cells begin at their N-terminus with methionine, and its removal by methionine aminopeptidase is often crucial, not only for biological function of the protein but even for cell survival. Aminopeptidases also play important roles in the food industry—for example, ripening of cheese (2) and production of soy sauce (3).

Aminopeptidases are inhibited by the antitumor antibiotic bestatin [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanol]-L-leucine, isolated from culture filtrates of Streptomyces olivoreticuli. It is a potent inhibitor of bovine lens aminopeptidases, with a Ki of 1.3 nM, and has numerous biological activities when administered to laboratory animals.

Membrane-bound aminopeptidases have often been identified on the basis of some other property, and then, once their amino acid sequence has been established, they are recognized to be aminopeptidases. Thus, the B-lymphocyte differentiation factor BP-1/6C3, whose expression correlates with proliferation and transformation of immature B cells (antibody-producing lymphocytes), has been shown to be identical to glutamyl aminopeptidase, also known as aminopeptidase A (4). Also the myeloid leukemia antigen CD-13 has been identified as aminopeptidase N (5), and the amino acid sequence of leukotriene A4 hydrolase revealed an aminopeptidase-like structure that led to the recognition of its aminopeptidase activity (6). Aminopeptidase N has also been shown to have a function unrelated to its enzymatic activity; that is, it serves as a cell-surface receptor for certain coronaviruses that cause upper respiratory infections (7).

 The amino acid sequence and three-dimensional structure of leucine aminopeptidase from bovine lens have been determined (8). This is a broad-specificity cytosolic enzyme found in tissues of all organisms. It has a high degree of sequence similarity to several other aminopeptidases, which suggests that they all share similar structures and catalytic mechanisms.

References

1. A. Taylor (1993) FASEB J. 7, 290–298. 

2. J. Meyer, D. Howald, R. Jordi, and M. Fuerst (1989) Milchwissenschaft 44, 678–681. 

3. T. Nakadai (1988) Nippon Shoyu Kenkyusho Zasshi 14, 50–56. 

4. Q. Wu et al. (1990) Proc. Natl. Acad. Sci. USA 87, 993–997. 

5. T. Inoue et al. (1994) J. Clin. Endocrinol. Metab. 79, 171–175. 

6. J. Z. Haeggstrom, A. Wetterholm, B. L. Vallee, and B. Samuelsson (1990) Biochem. Biophys. Res. Commun. 173, 431–437. 

7. B. Delmas et al. (1992) Nature 357, 417–420; Yeager et al. ibid. 420–422. 

8. S. K. Burley, P. R. David, A. Taylor, and W. N. Lipscomb (1990) Proc. Natl. Acad. Sci. USA 87, 6878–6882.    

اخر الاخبار

اخبار العتبة العباسية المقدسة

جمعية كشافة الكفيل: المجالس الحسينية تعلّم الفتية قيم نهضة الإمام الحسين (عليه السلام)

عَبرَ المجالس الحسينية.. المجمَع العلمي يقدّم محاضرات دينية وتلاوات قرآنية في بغداد والنجف وميسان

برعاية العتبة العباسية المقدسة.. موكب قناديل السماء يُحيي مراسم اليوم الثالث عشر من المحرّم

بعد انتهاء مراسم ذكرى دفن الأجساد الطاهرة قسم رعاية الصحن يباشر بحملة تنظيف واسعة لصحن مرقد أبي الفضل العباس (عليه السلام)

المزيد

الآخبار الصحية

لكبح الجوع وخسارة الوزن.. "سر بسيط" في نظام جوكوفيتش ؟

هل يساعد الرجيم في علاج الأمراض العقلية؟

لحماية أسنان طفلك.. هذا الفيتامين يقلل خطر التسوس

أكل الطعام بسرعة.. طريق سريع إلى أمراض خطيرة

المزيد

الآخبار التكنلوجية

ما هي أفضل درجة حرارة لتكييف الهواء في السيارة؟

ذوبان الأنهار الجليدية يوقظ "عمالقة نائمة"!

9 يوليو يشهد أقصر يوم في التاريخ المسجل ؟!!

راتبه عشرات ملايين الدولارات.. زوكربرغ يخطف "عقل أبل"

المزيد

مواضيع ذات صلة

Genome Editing of Immune Effector Cells for Safer and More Potent Cancer Therapies (CAR-T Cells)

Therapeutic Genome Editing for Hematologic Diseases: β-Thalassemia

Therapeutic Genome Editing for Hematologic Diseases: Sickle Cell Disease

TFIIIA Binding to the Middle of its Gene as Well as to RNA

Biology of 5S RNA Synthesis in Xenopus

Entropy, a Basis for Lambda Repressor Inactivation

Induction from the Lysogenic State

The Need for and the Realization of Hair-Trigger Induction

Site for Cro Repression and CI Activation

Chronology of Becoming a Lysogen

N Protein and Antitermination of Early Gene Transcription

Spontaneous Mutations in bacteria